-
Canaccord: DionyMed On Track For 'Strong' 2020
Monday, June 3, 2019 - 1:50pm | 410The multistate vertically integrated cannabis brand and delivery company DionyMed Brands Inc (OTC: DYMEF) reported Friday with first-quarter results which fell short of expectations, but the company is set up for a "strong" 2020, according to Canaccord Genuity. The Analyst Bobby Burleson...
-
Why This Analyst Cut iRobot's Price Target By $30
Thursday, October 26, 2017 - 8:53am | 329Analysts at Canaccord Genuity turned incrementally bearish on iRobot Corporation (NASDAQ: IRBT) after the company reported its third-quarter results. The firm's Bobby Burleson maintains a Hold rating on iRobot's stock with a price target slashed from $95 to $65, which implies zero upside potential...